Jan 7, 2020
Despite major investment in the field, few cell therapies have gained regulatory approval with limited commercial success.
The success of therapeutic products is defined by three factors: safety, efficacy and scalability. Achieving these for cell therapy presents new challenges; overcoming transplant rejection (and GvHD in the case of immune cells), producing and culturing functional cells and developing an off-the-shelf therapy with a scalable manufacturing process.
If you'd like to view the original article then follow the link below:
https://www.ddw-online.com/therapeutics/p323014-cell-therapy-falling-short-of-its-potential.html
You can also download the original article pdf here:
https://www.ddw-online.com/media/32/136359/(6)-cell-therapy.pdf
For more information on Drug Discovery World, head to: